➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Dow
Johnson and Johnson
Merck
AstraZeneca
Medtronic
Baxter

Last Updated: July 4, 2020

DrugPatentWatch Database Preview

Teligent Company Profile


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for TELIGENT, and what generic and branded alternatives to TELIGENT drugs are available?

TELIGENT has fifty-five approved drugs.



Summary for Teligent
US Patents:0
Tradenames:38
Ingredients:33
NDAs:55
Patent Litigation for Teligent: See patent lawsuits for Teligent

Drugs and US Patents for Teligent

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teligent ZINACEF cefuroxime sodium INJECTABLE;INJECTION 050558-004 Oct 23, 1986 AP RX Yes Yes   Start Trial   Start Trial
Teligent AQUAMEPHYTON phytonadione INJECTABLE;INJECTION 012223-001 Approved Prior to Jan 1, 1982 DISCN Yes No   Start Trial   Start Trial
Teligent FORTAZ ceftazidime INJECTABLE;INJECTION 050578-004 Jul 19, 1985 AP RX Yes Yes   Start Trial   Start Trial
Teligent Pharma Inc CEFOTAN cefotetan disodium INJECTABLE;INJECTION 063293-002 Apr 29, 1993 DISCN No No   Start Trial   Start Trial
Teligent Pharma Inc CLOBETASOL PROPIONATE clobetasol propionate GEL;TOPICAL 208881-001 Mar 6, 2017 AB RX No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for Teligent

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Teligent ZANTAC IN PLASTIC CONTAINER ranitidine hydrochloride INJECTABLE;INJECTION 019593-002 Sep 27, 1991 4,521,431*PED   Start Trial
Teligent ZANTAC IN PLASTIC CONTAINER ranitidine hydrochloride INJECTABLE;INJECTION 019593-002 Sep 27, 1991 4,128,659   Start Trial
Teligent ZANTAC ranitidine hydrochloride INJECTABLE;INJECTION 019090-001 Oct 19, 1984 4,128,658   Start Trial
Teligent ZANTAC IN PLASTIC CONTAINER ranitidine hydrochloride INJECTABLE;INJECTION 019593-002 Sep 27, 1991 4,585,790*PED   Start Trial
Teligent ZANTAC IN PLASTIC CONTAINER ranitidine hydrochloride INJECTABLE;INJECTION 019593-002 Sep 27, 1991 4,128,658   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Johnson and Johnson
McKesson
McKinsey
Mallinckrodt
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.